Phospho-tyrosine dependent protein-protein interaction network

Molecular Systems Biology

Volumn 11, Issue 3, 2015, Pages

  Grossmann, Arndt ^a   Benlasfer, Nouhad ^a   Birth, Petra ^a   Hegele, Anna ^a   Wachsmuth, Franziska ^a   Apelt, Luise ^a   Stelzl, Ulrich ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

cancer signaling; network biology; post translational protein modification; yeast two hybrid

Indexed keywords

PHOSPHOTYROSINE; TETRASPANIN; PHOSPHOPROTEIN; PROTEIN BINDING; PROTEIN KINASE; TYROSINE;

ARTICLE; BINDING ASSAY; CELL GROWTH; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; METABOLISM; PHOSPHORYLATION; TWO HYBRID SYSTEM;

MAMMALIA;

HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TWO-HYBRID SYSTEM TECHNIQUES; TYROSINE;

EID: 84925867326     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.15252/msb.20145968     Document Type: Article

References (62)

1. Bisson N, James DA, Ivosev G, Tate SA, Bonner R, Taylor L, Pawson T, (2011) Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat Biotechnol 29: 653-658
2. Blume-Jensen P, Hunter T, (2001) Oncogenic kinase signalling. Nature 411: 355-365
3. Blumenthal A, Giebel J, Ummanni R, Schluter R, Endlich K, Endlich N, (2012) Morphology and migration of podocytes are affected by CD151 levels. Am J Physiol Renal Physiol 302: F1265-F1277
4. Bordoli MR, Yum J, Breitkopf SB, Thon JN, Italiano JE Jr, Xiao J, Worby C, Wong SK, Lin G, Edenius M, Keller TL, Asara JM, Dixon JE, Yeo CY, Whitman M, (2014) A secreted tyrosine kinase acts in the extracellular environment. Cell 158: 1033-1044
5. Bradshaw JM, Waksman G, (2002) Molecular recognition by SH2 domains. Adv Protein Chem 61: 161-210
6. Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, Yu H, Sahalie JM, Murray RR, Roncari L, de Smet AS, Venkatesan K, Rual JF, Vandenhaute J, Cusick ME, Pawson T, Hill DE, Tavernier J, Wrana JL, Roth FP, Vidal M, (2009) An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 6: 91-97
7. Castro-Sanchez L, Soto-Guzman A, Navarro-Tito N, Martinez-Orozco R, Salazar EP, (2010) Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Eur J Cell Biol 89: 843-852
8. Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L, (2010) The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth. J Biol Chem 285: 38756-38764
9. Friedman A, Perrimon N, (2007) Genetic screening for signal transduction in the era of network biology. Cell 128: 225-231
10. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR, (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183
11. Hegele A, Kamburov A, Grossmann A, Sourlis C, Wowro S, Weimann M, Will CL, Pena V, Luhrmann R, Stelzl U, (2012) Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell 45: 567-580
12. Hemler ME, (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer 14: 49-60
13. Higo K, Ikura T, Oda M, Morii H, Takahashi J, Abe R, Ito N, (2013) High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28. PLoS ONE 8: e74482
14. Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, Latham V, Sullivan M, (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40: D261-D270
15. Huang H, Li L, Wu C, Schibli D, Colwill K, Ma S, Li C, Roy P, Ho K, Songyang Z, Pawson T, Gao Y, Li SS, (2008) Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics 7: 768-784
16. Ideker T, Krogan NJ, (2012) Differential network biology. Mol Syst Biol 8: 565
17. Kamburov A, Stelzl U, Lehrach H, Herwig R, (2013) The consensusPathDB interaction database: 2013 update. Nucleic Acids Res 41: D793-D800
18. Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H, Hamakawa H, (2005) CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem Biophys Res Commun 336: 408-416
19. Koytiger G, Kaushansky A, Gordus A, Rush J, Sorger PK, MacBeath G, (2013) Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected. Mol Cell Proteomics 12: 1204-1213
20. Lazo PA, (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666-1677
21. Lim WA, Pawson T, (2010) Phosphotyrosine signaling: evolving a new cellular communication system. Cell 142: 661-667
22. Linding R, Jensen LJ, Ostheimer GJ, van Vugt MA, Jorgensen C, Miron IM, Diella F, Colwill K, Taylor L, Elder K, Metalnikov P, Nguyen V, Pasculescu A, Jin J, Park JG, Samson LD, Woodgett JR, Russell RB, Bork P, Yaffe MB, et al, (2007) Systematic discovery of in vivo phosphorylation networks. Cell 129: 1415-1426
23. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, Nash PD, (2006) The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell 22: 851-868
24. Liu BA, Engelmann BW, Nash PD, (2012) The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction. FEBS Lett 586: 2597-2605
25. Mayer BJ, Jackson PK, Van Etten RA, Baltimore D, (1992) Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol Cell Biol 12: 609-618
26. Michnick SW, Ear PH, Manderson EN, Remy I, Stefan E, (2007) Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat Rev Drug Discov 6: 569-582
27. Miller ML, Jensen LJ, Diella F, Jorgensen C, Tinti M, Li L, Hsiung M, Parker SA, Bordeaux J, Sicheritz-Ponten T, Olhovsky M, Pasculescu A, Alexander J, Knapp S, Blom N, Bork P, Li S, Cesareni G, Pawson T, Turk BE, et al, (2008) Linear motif atlas for phosphorylation-dependent signaling. Sci Signal 1: ra2
28. Moritz A, Li Y, Guo A, Villen J, Wang Y, MacNeill J, Kornhauser J, Sprott K, Zhou J, Possemato A, Ren JM, Hornbeck P, Cantley LC, Gygi SP, Rush J, Comb MJ, (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 3: ra64
29. Mothe I, Delahaye L, Filloux C, Pons S, White MF, Van Obberghen E, (1997) Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins. Mol Endocrinol 11: 1911-1923
30. Murayama Y, Miyagawa J, Oritani K, Yoshida H, Yamamoto K, Kishida O, Miyazaki T, Tsutsui S, Kiyohara T, Miyazaki Y, Higashiyama S, Matsuzawa Y, Shinomura Y, (2004) CD9-mediated activation of the p46 Shc isoform leads to apoptosis in cancer cells. J Cell Sci 117: 3379-3388
31. Murayama Y, Shinomura Y, Oritani K, Miyagawa J, Yoshida H, Nishida M, Katsube F, Shiraga M, Miyazaki T, Nakamoto T, Tsutsui S, Tamura S, Higashiyama S, Shimomura I, Hayashi N, (2008) The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol 216: 135-143
32. Myers MG Jr, Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF, (1992) IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci USA 89: 10350-10354
33. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M, (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3: ra3
34. Otsubo C, Otomo R, Miyazaki M, Matsushima-Hibiya Y, Kohno T, Iwakawa R, Takeshita F, Okayama H, Ichikawa H, Saya H, Kiyono T, Ochiya T, Tashiro F, Nakagama H, Yokota J, Enari M, (2014) TSPAN2 is involved in cell invasion and motility during lung cancer progression. Cell Rep 7: 527-538
35. Rahuel J, Gay B, Erdmann D, Strauss A, Garcia-Echeverria C, Furet P, Caravatti G, Fretz H, Schoepfer J, Grutter MG, (1996) Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat Struct Biol 3: 586-589
36. Rolland T, Tasan M, Charloteaux B, Pevzner SJ, Zhong Q, Sahni N, Yi S, Lemmens I, Fontanillo C, Mosca R, Kamburov A, Ghiassian SD, Yang X, Ghamsari L, Balcha D, Begg BE, Braun P, Brehme M, Broly MP, Carvunis AR, et al, (2014) A proteome-scale map of the human interactome network. Cell 159: 1212-1226
37. Sadej R, Grudowska A, Turczyk L, Kordek R, Romanska HM, (2014) CD151 in cancer progression and metastasis: a complex scenario. Lab Invest 94: 41-51
38. Schlessinger J, Lemmon MA, (2003) SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003: RE12
39. Seet BT, Dikic I, Zhou MM, Pawson T, (2006) Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 7: 473-483
40. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC, (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778
41. Songyang Z, Cantley LC, (2004) ZIP codes for delivering SH2 domains. Cell 116: 41-43
42. Stefan E, Malleshaiah MK, Breton B, Ear PH, Bachmann V, Beyermann M, Bouvier M, Michnick SW, (2011) PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascades. Nat Commun 2: 598
43. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, Bock N, Kietzmann S, Goedde A, Toksoz E, Droege A, Krobitsch S, Korn B, et al, (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968
44. Stelzl U, (2013) Molecular interaction networks in the analyses of sequence variation and proteomics data. Proteomics Clin Appl 7: 727-732
45. Stotz A, Linder P, (1990) The ADE2 gene from Saccharomyces cerevisiae: sequence and new vectors. Gene 95: 91-98
46. Tan CS, Bodenmiller B, Pasculescu A, Jovanovic M, Hengartner MO, Jorgensen C, Bader GD, Aebersold R, Pawson T, Linding R, (2009) Comparative analysis reveals conserved protein phosphorylation networks implicated in multiple diseases. Sci Signal 2: ra39
47. Tinti M, Kiemer L, Costa S, Miller ML, Sacco F, Olsen JV, Carducci M, Paoluzi S, Langone F, Workman CT, Blom N, Machida K, Thompson CM, Schutkowski M, Brunak S, Mann M, Mayer BJ, Castagnoli L, Cesareni G, (2013) The SH2 domain interaction landscape. Cell Rep 3: 1293-1305
48. Varjosalo M, Bjorklund M, Cheng F, Syvanen H, Kivioja T, Kilpinen S, Sun Z, Kallioniemi O, Stunnenberg HG, He WW, Ojala P, Taipale J, (2008) Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 133: 537-548
49. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, Hirozane-Kishikawa T, Hao T, Zenkner M, Xin X, Goh KI, Yildirim MA, Simonis N, Heinzmann K, Gebreab F, Sahalie JM, Cevik S, Simon C, de Smet AS, Dann E, Smolyar A, et al, (2009) An empirical framework for binary interactome mapping. Nat Methods 6: 83-90
50. Vidal M, Cusick ME, Barabasi AL, (2011) Interactome networks and human disease. Cell 144: 986-998
51. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, Assmus HE, Andrade-Navarro MA, Wanker EE, (2011) A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 4: rs8
52. Wang HX, Kolesnikova TV, Denison C, Gygi SP, Hemler ME, (2011) The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci 124: 2702-2710
53. Wei X, Das J, Fragoza R, Liang J, Bastos de Oliveira FM, Lee HR, Wang X, Mort M, Stenson PD, Cooper DN, Lipkin SM, Smolka MB, Yu H, (2014) A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations. PLoS Genet 10: e1004819
54. Weimann M, Grossmann A, Woodsmith J, Ozkan Z, Birth P, Meierhofer D, Benlasfer N, Valovka T, Timmermann B, Wanker EE, Sauer S, Stelzl U, (2013) A Y2H-seq approach defines the human protein methyltransferase interactome. Nat Methods 10: 339-342
55. Wong KK, Engelman JA, Cantley LC, (2010) Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 20: 87-90
56. Woodsmith J, Kamburov A, Stelzl U, (2013) Dual coordination of post translational modifications in human protein networks. PLoS Comput Biol 9: e1002933
57. Woodsmith J, Stelzl U, (2014) Studying post-translational modifications with protein interaction networks. Curr Opin Struct Biol 24C: 34-44
58. Worseck JM, Grossmann A, Weimann M, Hegele A, Stelzl U, (2012) A stringent yeast two-hybrid matrix screening approach for protein-protein interaction discovery. Methods Mol Biol 812: 63-87
59. Yamada M, Sumida Y, Fujibayashi A, Fukaguchi K, Sanzen N, Nishiuchi R, Sekiguchi K, (2008) The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511. FEBS J 275: 3335-3351
60. Yaoi T, Chamnongpol S, Jiang X, Li X, (2006) Src homology 2 domain-based high throughput assays for profiling downstream molecules in receptor tyrosine kinase pathways. Mol Cell Proteomics 5: 959-968
61. Zheng Y, Zhang C, Croucher DR, Soliman MA, St-Denis N, Pasculescu A, Taylor L, Tate SA, Hardy WR, Colwill K, Dai AY, Bagshaw R, Dennis JW, Gingras AC, Daly RJ, Pawson T, (2013) Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499: 166-171
62. Zhong Q, Simonis N, Li QR, Charloteaux B, Heuze F, Klitgord N, Tam S, Yu H, Venkatesan K, Mou D, Swearingen V, Yildirim MA, Yan H, Dricot A, Szeto D, Lin C, Hao T, Fan C, Milstein S, Dupuy D, et al, (2009) Edgetic perturbation models of human inherited disorders. Mol Syst Biol 5: 321